| Symbol |
Name |
|
ABCC8
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ADAM10
|
ADAM metallopeptidase domain 10
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
AGER
|
advanced glycosylation end product-specific receptor
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALK
|
anaplastic lymphoma receptor tyrosine kinase
|
|
ANXA5
|
annexin A5
|
|
APC
|
adenomatous polyposis coli
|
|
APOA1
|
apolipoprotein A-I
|
|
APOB
|
apolipoprotein B
|
|
APOE
|
apolipoprotein E
|
|
ARID1A
|
AT rich interactive domain 1A (SWI-like)
|
|
ASCL1
|
achaete-scute family bHLH transcription factor 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BRCA2
|
breast cancer 2, early onset
|
|
C3
|
complement component 3
|
|
C9
|
complement component 9
|
|
CARD9
|
caspase recruitment domain family, member 9
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCR1
|
chemokine (C-C motif) receptor 1
|
|
CCT2
|
chaperonin containing TCP1, subunit 2 (beta)
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD59
|
CD59 molecule, complement regulatory protein
|
|
CDH2
|
cadherin 2, type 1, N-cadherin (neuronal)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CHEK2
|
checkpoint kinase 2
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CST3
|
cystatin C
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTTN
|
cortactin
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP4V2
|
cytochrome P450, family 4, subfamily V, polypeptide 2
|
|
DEK
|
DEK proto-oncogene
|
|
DMD
|
dystrophin
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPYD
|
dihydropyrimidine dehydrogenase
|
|
DRD2
|
dopamine receptor D2
|
|
EGFR
|
epidermal growth factor receptor
|
|
ELAVL1
|
ELAV like RNA binding protein 1
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
F11
|
coagulation factor XI
|
|
F13A1
|
coagulation factor XIII, A1 polypeptide
|
|
F2
|
coagulation factor II (thrombin)
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FECH
|
ferrochelatase
|
|
FGA
|
fibrinogen alpha chain
|
|
FGG
|
fibrinogen gamma chain
|
|
FOXF1
|
forkhead box F1
|
|
FOXP1
|
forkhead box P1
|
|
FST
|
follistatin
|
|
GNA11
|
guanine nucleotide binding protein (G protein), alpha 11 (Gq class)
|
|
GNAQ
|
guanine nucleotide binding protein (G protein), q polypeptide
|
|
GP6
|
glycoprotein VI (platelet)
|
|
HADH
|
hydroxyacyl-CoA dehydrogenase
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
IL10
|
interleukin 10
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL18
|
interleukin 18
|
|
IL1B
|
interleukin 1, beta
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL23A
|
interleukin 23, alpha subunit p19
|
|
IL6
|
interleukin 6
|
|
INHBA
|
inhibin, beta A
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNAB1
|
potassium channel, voltage gated subfamily A regulatory beta subunit 1
|
|
KCND3
|
potassium channel, voltage gated Shal related subfamily D, member 3
|
|
LIPG
|
lipase, endothelial
|
|
LRRK2
|
leucine-rich repeat kinase 2
|
|
LTF
|
lactotransferrin
|
|
MEFV
|
Mediterranean fever
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MMP12
|
matrix metallopeptidase 12
|
|
MMP13
|
matrix metallopeptidase 13
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP26
|
matrix metallopeptidase 26
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP7
|
matrix metallopeptidase 7
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MT-ATP6
|
ATP synthase F0 subunit 6
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTM1
|
myotubularin 1
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTRR
|
5-methyltetrahydrofolate-homocysteine methyltransferase reductase
|
|
MUC2
|
mucin 2, oligomeric mucus/gel-forming
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MUC6
|
mucin 6, oligomeric mucus/gel-forming
|
|
NCSTN
|
nicastrin
|
|
NEFL
|
neurofilament, light polypeptide
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFIB
|
nuclear factor I/B
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH3
|
notch 3
|
|
NPY
|
neuropeptide Y
|
|
OFD1
|
oral-facial-digital syndrome 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX6
|
paired box 6
|
|
PDCD5
|
programmed cell death 5
|
|
PF4
|
platelet factor 4
|
|
PGR
|
progesterone receptor
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PLG
|
plasminogen
|
|
PMM2
|
phosphomannomutase 2
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PRKCH
|
protein kinase C, eta
|
|
PRNP
|
prion protein
|
|
PROC
|
protein C (inactivator of coagulation factors Va and VIIIa)
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROS1
|
protein S (alpha)
|
|
PTGIR
|
prostaglandin I2 (prostacyclin) receptor (IP)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
RAB7A
|
RAB7A, member RAS oncogene family
|
|
RB1
|
retinoblastoma 1
|
|
RBM20
|
RNA binding motif protein 20
|
|
RUNX2
|
runt-related transcription factor 2
|
|
S100B
|
S100 calcium binding protein B
|
|
SCN8A
|
sodium channel, voltage gated, type VIII alpha subunit
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SFRP4
|
secreted frizzled-related protein 4
|
|
SGCE
|
sarcoglycan, epsilon
|
|
SLC12A3
|
solute carrier family 12 (sodium/chloride transporter), member 3
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC33A1
|
solute carrier family 33 (acetyl-CoA transporter), member 1
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SMYD3
|
SET and MYND domain containing 3
|
|
SPECC1L
|
sperm antigen with calponin homology and coiled-coil domains 1-like
|
|
SPECC1L-ADORA2A
|
SPECC1L-ADORA2A readthrough (NMD candidate)
|
|
SRSF1
|
serine/arginine-rich splicing factor 1
|
|
TET2
|
tet methylcytosine dioxygenase 2
|
|
TFPI
|
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)
|
|
TFPI2
|
tissue factor pathway inhibitor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
TNF
|
tumor necrosis factor
|
|
TNFSF13B
|
tumor necrosis factor (ligand) superfamily, member 13b
|
|
TOR1A
|
torsin family 1, member A (torsin A)
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
|
USH2A
|
Usher syndrome 2A (autosomal recessive, mild)
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
WT1
|
Wilms tumor 1
|
